SCHEMBL7708546

SCHEMBL7708546

COc1csc(-c2nc3cc(-c4ccc(F)cc4)cc(N)n3n2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
KDM4E B2RXH2 3/20 0.42
ALDH1A1 P00352 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
PKM P14618 1/20 0.42
HPGD P15428 1/20 0.42
CDK5 Q00535 1/20 0.42
CDK5R1 Q15078 1/20 0.42
BACE1 P56817 1/20 0.36
CYP1B1 Q16678 2/20 0.35
FLT3 P36888 1/20 0.35
CYP1A1 P04798 1/20 0.35
KMT2A Q03164 4/20 0.35
MEN1 O00255 2/20 0.35
RXFP1 Q9HBX9 1/20 0.35
ALDH1A3 P47895 1/20 0.34
MAPT P10636 3/20 0.34
SRC P12931 1/20 0.34
BRAF P15056 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7711838 0.92 SMN1; SMN2 (0.50) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL7711818 0.89 ALDH1A1 (0.42) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL7705877 0.89 SMN1; SMN2 (0.41) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL7708772 0.89 SMN1; SMN2 (0.38) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL7705875 0.83 TP53 (0.42) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL7433615 0.79 KDM4E (0.39) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL7709149 0.77 FYN (0.46) MAPTBRAF
SCHEMBL7708784 0.73 SMN1; SMN2 (0.54) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL7708503 0.72 NPC1 (0.53) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL7708891 0.71 KDM4E (0.49) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6355653-B1 DRUG AND CARRIER FOR ANTIALLERGENS, BRAIN DISORDERS AND NEUROTRANSMITTERS HOFFMANN-LA ROCHE INC. 2002-03-12 US disclosed